MMManuela Maria Viana Miguel

Manuela Maria Viana Miguel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manuela Maria Viana Miguel has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Local immunoinflammatory profiles following treatment in primary and permanent dentitions in molar‐incisor pattern periodontitis: One‐year follow‐up

    by Luciana S. Branco‐De‐Almeida, Judy Anjary, Hong Huang, Manuela Maria Viana Miguel, Peter Harrison, Ikramuddin Aukhil, Luciana M. Shaddox

    Background: The aim of this study is to evaluate the gingival crevicular fluid (GCF) levels of inflammatory markers in both primary and permanent dentitions affected with grade C molar‐incisor pattern periodontitis (C‐MIP) before and after periodontal therapy. Methods: Patients from an African American cohort (both sexes; aged 5‐21 years) diagnosed with C‐MIP in the primary ( n = 26) or permanent ( n = 44) dentitions were included. After periodontal evaluations, patients received non‐surgical periodontal treatment (mechanical debridement with cavitron and hand scaling as needed and 1 week of systemic amoxicillin/metronidazole regimen with dosage modifications for patients weighing under 40 kg). GCF samples were collected from both healthy and diseased sites at baseline, and at 3‐, 6‐, and 12‐months post‐therapy, during periodontal maintenance. Levels of 14 cytokines/chemokines were analyzed using multiplex. GCF levels between primary and permanent dentitions and among timepoints were evaluated along with clinical parameters (e.g., probing depth [PD], clinical attachment level, bleeding on probing [BoP], and plaque [PI]). Results: Overall, clinical parameters were improved following treatment in both dentitions up to 12 months. Several cytokines/chemokines were higher in the diseased sites compared with the healthy sites at baseline in both dentitions ( p < 0.05). Following treatment, eotaxin reduced in both dentitions in diseased sites ( p < 0.05), while other markers were specifically reduced in the permanent (granulocyte‐macrophage colony‐stimulating factor [GM‐CSF], interleukin [IL]‐1β, IL‐6, IL‐8, IL‐12p40, tumor necrosis factor‐alpha [TNF‐α]) dentition. However, some markers, such as eotaxin, IL‐1β, IL‐2, IL‐8, IL‐10, IL‐12p40, MIP‐1α and TNF‐α although reduced by 3‐, 6‐months, showed a tendency of rebound by 6 and 12 months, especially in permanent dentition. Eotaxin and MCP‐1 were higher in diseased sites at baseline in the permanent dentition while GM‐CSF and interferon‐gamma [IFN‐γ] in the primary one ( p < 0.05). Several cytokines/chemokines were correlated with clinical parameter reductions, and profile analysis showed differences between dentitions up to 6 months. Conclusion: Non‐surgical therapy combined with systemic antibiotics improved clinical (e.g., PD, CAL, and number of affected sites) outcomes with reductions in pro‐inflammatory cytokine/chemokine levels in both primary and permanent dentitions of patients with C‐MIP in the long term, with some specific differences observed between the dentitions (NCT01330719).

  • Treatment of single gingival recessions using iPRF‐biofunctionalized collagen matrix: A randomized clinical trial

    by Mauro Pedrine Santamaria, Amanda Rossato, Manuela Maria Viana Miguel, Ana Carolina Ferreira Bonafé, Ingrid Fernandes Mathias‐Santamaria, Marcelo Pereira Nunes

    Background: The biofunctionalization of collagen matrices (CMs) with injectable platelet‐rich fibrin (i‐PRF) has been proposed to enhance their bioactivity and clinical efficacy in the treatment of gingival recessions (GRs). This study evaluated the use of a volume‐stable collagen matrix (VCMX) biofunctionalized with i‐PRF as an adjunct to the coronally advanced flap (CAF) for single GRs. Methods: Seventy‐five patients with single RT1 GR were randomly assigned to CAF, CAF+VCMX, or CAF+VCMX+iPRF. Clinical, esthetic, and patient‐centered outcomes were assessed at baseline and at 6 months. Results: All groups resulted in significant recession reduction (CAF: 1.93 ± 0.86 mm; CAF+VCMX: 1.64 ± 0.68 mm; CAF+VCMX+iPRF: 1.70 ± 0.84 mm), with no statistically significant differences among groups ( p = 0.36). Groups treated with VCMX showed greater gingival thickness (GT) gain (CAF: 0.18 ± 0.25 mm; CAF+VCMX: 0.39 ± 0.26 mm; CAF+VCMX+iPRF: 0.45 ± 0.29 mm), favoring CAF+VCMX+iPRF ( p < 0.001). No significant keratinized tissue width (KTW) gain was observed ( p > 0.05). Adjusted models identified baseline KTW and KTW gain as positive predictors of complete root coverage (CRC), and KTW gain as the main predictor for RecRed and %RC. Conclusions: All approaches were effective in reducing GR and improving clinical parameters. The iPRF addition to the VCMX may not improve root coverage outcomes (NCT05916742). Plain language summary: Gingival recession, or receding gums, occurs when the gum moves away from the tooth, exposing the root of the tooth. This can cause sensitivity and esthetic concerns and increase the tooth's susceptibility to problems. A common surgical treatment is the coronally advanced flap (CAF), which repositions the gum to cover the exposed root. In some cases, dentists add a collagen matrix to help thicken the gum and to improve the outcome. A newer option enhances this matrix with a patient's own blood product called injectable platelet‐rich fibrin (i‐PRF), which may improve healing. This study included 75 patients with a single recession defect. They were randomly assigned to one of three treatments: CAF alone, CAF with a collagen matrix, or CAF with a collagen matrix enhanced with i‐PRF. After 6 months, all treatments led to similar improvements in root coverage, sensitivity, and esthetics. However, patients who received the collagen matrix, especially when combined with i‐PRF, developed thicker gum tissue. Thicker and wider gum tissue is associated with better long‐term outcomes. All procedures were well tolerated and caused minimal discomfort. Overall, adding a collagen matrix, particularly when enhanced with i‐PRF, may support thicker gums and help to maintain long‐term results.


  • Salivary NLRP3 inflammasome as a promising biomarker for palatal mucosa healing in diabetes mellitus: A pilot study

    by Manuela Maria Viana Miguel, Ana Carolina Ferreira Bonafé, Ingrid Fernandes Mathias‐Santamaria, D. Travis Thomas, Luciana Macchion Shaddox, Mauro Pedrine Santamaria

    Background: The NOD‐like receptor family pyrin domain‐containing protein 3 (NLRP3) inflammasome is a protein complex that regulates IL‐1β activation. Despite its known role in dermal healing, its involvement in oral mucosal healing remains poorly understood. Methods: Twenty‐four subjects, including 12 with Type 2 diabetes mellitus (T2DM) and 12 normoglycemic controls (C), underwent a surgical procedure for mucogingival defect treatment in which a graft was harvested from the palate. The palatal wound was assessed for remaining wound area (RWA) and epithelialization (EPT) until 3 months. Wound exudate was collected on days 3 and 7 post‐operatively to analyze inflammatory biomarkers, proteinases, and growth factors. NLRP3, PYCARD, CASPASE‐1, and interleukin‐1beta (IL‐1β) salivary levels were assessed preoperatively and 7 days post‐surgery. Results: Lower EPT rates and greater RWA were observed in T2DM compared to Control on days 7 and 14 postoperatively. Higher MMP‐9 concentration was detected in T2DM subjects on days 3 and 7 post‐surgery ( p < 0.05). Salivary NLRP3 and PYCARD increased in the C group at 7 days post‐surgery ( p ≤ 0.04), whereas IL‐1β was higher over time in the T2DM group ( p = 0.003). At baseline, NLRP3 and PYCARD levels were higher in T2DM ( p ≤ 0.005), whereas PYCARD ( p = 0.01) and CASPASE‐1 ( p = 0.05) remained elevated at 7 days compared with C. A positive association between salivary NLRP3 levels with IL‐1β ( r = 0.46) and tumor necrosis factor‐alpha (TNF‐ α ) ( r = 0.47) from wound exudate on day 7 was observed. PYCARD levels associated with IL‐1β ( r = 0.48) and TNF‐ α ( r = 0.50) at the same time point. Principal component analysis of inflammasome‐related markers and wound biomarkers on day 7 suggested a potential impact on delayed wound closure by day 14. Conclusion: The NLRP3 inflammasome may be a promising biomarker for T2DM‐related acute palatal healing due to its early upregulation and association with proinflammatory markers, with a potential impact on delayed wound closure.

  • Grade C molar‐incisor pattern periodontitis classification and its challenges

    by Yasmin Teixeira das Graças, Manuela Maria Viana Miguel, Renato Corrêa Viana Casarin, Mauro Pedrine Santamaria, Pratishtha Mishra, Luciana Macchion Shaddox

    Background: The classification of periodontitis has changed, establishing not just the severity and extent of disease but also more comprehensive risk assessment for patients and hopefully guiding more tailored treatment approaches. Although the new classification presented several benefits to the severity and risk of progression of disease, some limitations remain. This review highlights key gaps in the grade C and molar‐incisor pattern (C‐MIP) classification, particularly the exclusion of primary dentition involvement, which limits early awareness, diagnosis, treatment, and research. Additionally, the current “grade C” category includes a broad spectrum of patients, ranging from systemically healthy young individuals with early onset and rapid disease progression to older adults whose disease is associated with modifying factors. This overlap masks key clinical and biological differences, complicating efforts to identify susceptibility profiles and tailor treatment. Moreover, cases extending beyond the molar‐incisor pattern, including premolars or atypical presentations, pose challenges to the current classification system. These patients often exhibit early onset, familial aggregation, rapid progression, and absence of systemic risk factors, suggesting a unique susceptibility profile that may not be adequately captured by the current classification and deserve proper categorization to be better studied and treated. Conclusion: In the conclusion of this paper, we suggest expansion and clarification of the current classification system to: (1) recognize periodontitis in the primary dentition; (2) distinguish patients with grade C periodontitis by the presence or absence of modifying factors; and (3) introduce a subclassification for grade C cases predominantly affecting young patients. These refinements may improve diagnostic accuracy and support more targeted research, prevention, and treatment for at‐risk youth.


  • Open Access

    Localized Periodontitis in Young Individuals: Aggregatibacter JP2 Clone, Immunological Dysfunctions and Other Stories

    by Luigi Nibali, Meaad M. Alamri, Manuela Maria Viana Miguel, Luciana Shaddox

    Grade C molar‐incisor pattern periodontitis (C‐MIP) is the latest in a series of names given to a unique phenotype, characterized by an aggressive and rapid loss of tooth‐supporting structures, starting early in life and usually affecting first molars and incisors. Although much less prevalent than the more generalized “chronic” forms of this disease in adults, it affects mostly young individuals of lower socioeconomic status and African descent, or from mixed‐race populations, and shows a strong familial aggregation, pointing to a possible genetic contribution, yet not fully elucidated. Even though most of the studies report this disease in adolescents/young adults, it can also be diagnosed in the primary dentition, frequently in the first molar. Thus, proper periodontal examination and radiographs in children are crucial for early diagnosis and treatment. The rapid periodontal breakdown in this disease is also associated with specific microorganisms and a dysfunctional inflammatory response of the host. A. actinomycetemcomitans has been strongly implicated in C‐MIP severity and progression, although newer technologies have pointed to the influence of other associated species implicated in this disease in different populations. Additionally, a pro‐inflammatory profile along with hypo/hyperactivity of the cellular innate response has been observed in C‐MIP. Genetic studies have supported evidence of family aggregation, although specific genes are yet to be identified. Several clinical therapies have been proposed to treat C‐MIP over time, and non‐surgical periodontal therapy with adjunctive systemic antibiotics has shown a favorable impact on clinical, immunological, and microbiological outcomes in the short and long term in both primary and permanent dentition. This paper aims to review this unique disease, its proposed pathogenic mechanisms, risk factors, treatment outcomes, and the remaining gaps that still require investigation.


  • Guided‐modified coronally advanced flap: Novel digital approach to treat multiple gingival recessions. Workflow and case study

    by Mauro Pedrine Santamaria, Ana Carolina Ferreira Bonafé, Amanda Rossato, Manuela Maria Viana Miguel, Andrews Porto da Costa, Ingrid Fernandes Mathias‐Santamaria, Marcelo Pereira Nunes, Lucas Araújo Queiroz

    Background: Gingival recession (GR) poses esthetic and functional challenges for patients, particularly in cases of multiple adjacent defects. Traditional surgical approaches, such as the modified coronally advanced flap (MCAF) with connective tissue grafts (CTG), demand high levels of precision and skill, making outcomes reliant on clinician expertize. The integration of digital technologies, including cone‐beam computed tomography (CBCT) and computer‐aided design and manufacturing (CAD–CAM), offers a novel, standardized approach to enhance procedural accuracy and predictability. Methods: This case study describes the use of the guided‐modified coronally advanced flap (g‐MCAF) for the treatment of multiple GR defects. A patient whose main concern was the esthetic appearance of her teeth was treated. Using an intraoral scanner, CBCT data, and CAD‐CAM software, surgical guides were designed and 3D printed using a dedicated resin, assuring precise adaptation to the patients’ teeth. The guides delineated MCAF oblique incisions and free gingival graft dimensions tailored to fit into the area, facilitating flap design, and graft harvesting. Results: The guided MCAF (g‐MCAF) procedure successfully achieved complete root coverage. At the 6‐month follow‐up, recession reduction was observed, measuring 2.22 mm for tooth #5, 2.59 mm for tooth #6, and 2.26 mm for tooth #7. Gingival thickness also increased, reaching 1.23, 1.16, and 1.45 mm, respectively. Additionally, the patient reported improved esthetics and reduced hypersensitivity. Conclusion: The g‐MCAF technique may have the potential to serve as a reliable aid to execute MCAF in the management of multiple GR defects. Key points: A guided surgical approach (g‐MCAF) using digital technologies allows for precise flap design and graft harvesting, which may help control variability and minimize errors during root coverage procedures. The integration of CBCT, intraoral scanning, and CAD–CAM technologies supports preoperative planning, potentially contributing to safer and more predictable outcomes, particularly in cases requiring connective tissue grafts. This innovative approach may assist in simplifying complex surgical techniques, improving clinician confidence, and serving as both a clinical and an educational tool for periodontal plastic surgery.


  • Omega‐3 and aspirin in the nonsurgical treatment of grade C periodontitis: A randomized clinical trial

    by Cássia F. Araujo, Naira M. R. B. Andere, Nidia C. Castro dos Santos, Laís F. F. Ferraz, Manuela M. V. Miguel, Ingrid F. Mathias‐Santamaria, Mabelle F. Monteiro, Luciana M. Shaddox, Renato C. V. Casarin, Mauro P. Santamaria

    Background: The use of omega‐3 (Ω‐3) polyunsaturated fatty acids and acetylsalicylic acid (ASA, aspirin) has shown better clinical outcomes in the treatment of periodontitis compared to nonsurgical periodontal therapy (NSPT) alone. This randomized clinical trial aimed to evaluate the use of 900 mg Ω‐3 and 100 mg ASA for 180 days as adjuncts to NSPT for generalized stage III–IV grade C periodontitis (GCP).Methods: Patients underwent subgingival debridement (SD) associated with Ω‐3+ASA or cellulose placebo and received monthly prophylaxis. Clinical and immunological parameters were compared at baseline, 3, and 6 months after treatment. The daily dose of Ω‐3 consisted of 540 mg eicosapentaenoic acid (EPA) and 360 mg docosahexaenoic acid (DHA).Results: Thirty‐eight patients, 12 males (7 in the SD+Ω‐3+AAS group and 5 in the SD+Placebo group; p > 0.05), with a mean age of 32.84 ± 5.47 and 30.42 ± 5.79 years, respectively (p > 0.05), were included. Both groups showed significant improvements (p < 0.05) in all full‐mouth parameters. Reductions in the number of pockets, mean probing depth (PD), and clinical attachment level of moderate and deep sites, as well as the number and percentage of residual pockets, were observed (intragroup p < 0.05; intergroup p > 0.05). However, residual pockets' mean PD decrease (p < 0.05) was only observed at 6 months in the SD+Ω‐3+ASA group. The concentration of interleukin (IL)‐1β from moderate and deep pockets decreased (p < 0.05) in both groups. The matrix metalloproteinase (MMP)‐9 to tissue metalloproteinase inhibitor (TIMP)‐1 ratio in the SD+Placebo group at 3 months revealed a proinflammatory profile in moderate (intergroup p = 0.006) and deep pockets (intergroup p < 0.001).Conclusion: Ω‐3+ASA therapy did not add clinical benefits to the NSPT for generalized stage III–IV GCP, although some immunomodulatory benefits could be observed.Plain Language Summary: The use of omega‐3 (Ω‐3) and aspirin (ASA) along with subgingival debridement (SD) for root decontamination of periodontal pockets has shown better results in the nonsurgical treatment of gum disease and bone loss compared to SD alone. This investigation aimed to evaluate the use of 900 mg Ω‐3 and 100 mg ASA for 180 days as adjuncts to the treatment of patients with gum disease and rapid bone loss rate. Thirty‐eight patients underwent SD associated with Ω‐3+ASA or placebo. Clinical and immunological parameters were evaluated at the beginning of the study and 3 and 6 months after. Both groups showed significant improvements. A significant reduction in the number of sites with diseased pockets was observed. The number of residual diseased sites was also significantly reduced, without differences between the groups. However, a significant decrease in the pocket size of the diseased sites was only observed at 6 months in the group that received Ω‐3+ASA. The concentration of interleukin (IL)‐1β (a protein present in the inflammatory process) from diseased sites significantly decreased in both groups. We concluded that the proposed therapy did not add any significant clinical benefits for patients with gum disease and rapid bone loss rate.


  • Microbiome and Inflammatory Biomarkers Associated With Palatal Wound Healing

    by Mauro Pedrine Santamaria, Ingrid Fernandes Mathias‐Santamaria, Ana Carolina Ferreira Bonafé, Octavio A. Gonzalez, Sreenatha Kirakodu, Mabelle de Freitas Monteiro, Renato Corrêa Vianna Casarin, Luciana Macchion Shaddox, Manuela Maria Viana Miguel

    Aim: The clinical outcomes of a variety of surgical procedures highly depend on tissue repair and show high variability among patients. There is a gap in the literature on how the host inflammatory response, the microbiome, and the interplay between them can influence oral mucosa healing. In this pilot study, we aimed to evaluate the microbiome and biomarkers profiles in patients who had desired versus undesired wound healing in the palatal mucosa.Methods: Seventeen patients underwent a free gingival graft (FGG) for socket preservation. Palatal wound closure (WC) and epithelization (EPT) were assessed clinically. Biofilm from the palatal wound was collected before the surgical procedure and 3, 7, 14, and 30 days postoperatively. The inflammatory exudate was sampled on Days 3 and 7. At 14 days posttreatment, patients were classified into two groups based on EPT rates: (1) undesired healing (UH) and (2) desired healing (DH).Results: No difference was observed in alfa diversity over time or between groups. In beta diversity, both UH and DH showed microbiome changes on Days 3–7 and 7, respectively, compared with the baseline (p = 0.01), returning to its initial condition 30 days later. There was a trend toward a different microbiome profile between groups on Day 7 (p = 0.08). Bacterium composition in DH showed a balance between healthy species and oral pathogens over time, whereas UH composition was characterized by microorganisms correlated with epithelium invasion/cytotoxicity; virulence factor upregulation; and oral diseases, such as periodontitis and aphthous stomatitis, until Day 30. UH showed an increase in IL‐6, MCP‐1, and MIP‐1α over time, and DH showed a decrease in TIMP‐1, IL‐1β, and MIP‐1α. On Days 3 and 7, MIP‐1α and MMP‐2 showed greater concentrations of DH in the intergroup assessment, and MCP‐1 increased on Day 7 in UH.Conclusion: Specific microbiome/inflammatory profiles are associated with DH and UH.Trial Registration: NCT05171400


  • Impact of dietary inflammatory index on gingival health

    by Roberta Andrade Reis, Camila Schmidt Stolf, Helena Alves de Carvalho Sampaio, Bruna Yhang da Costa Silva, Tuğçe Özlü, Emre Batuhan Kenger, Manuela Maria Vianal Miguel, Mauro Pedrine Santamaria, Mabelle de Freitas Monteiro, Marcio Zaffalon Casati, et al.

    Background: Periodontal disease is a biofilm‐dependent chronic inflammatory condition triggered by a host response. Several factors impact systemic inflammation and could lead to changes in disease pathogenesis. Recently, studies have assessed the influence of nutritional patterns on the development of periodontitis. In the present cross‐sectional study, we evaluated the dietary inflammatory profile on periodontal conditions, focusing on clinical, subgingival microbial, and cytokine assessment of individuals with periodontal health or gingivitis.Methods: One hundred patients with periodontal health or gingivitis were included. Plaque index (PI), Bleeding on probing (BoP), the probing depth (PD), and the clinical attachment level (CAL) for each patient were assessed. Nutritional data and the Dietary Inflammatory Index (DII) were recorded by two 24‐h food recalls on non‐consecutive days. Biofilm and gingival crevicular fluid (GCF) to assess the microbiome profile and inflammatory biomarkers were collected. Multiple regressions focused on the DII, age, and sex as predictors of periodontal conditions were done.Results: Age and moderate DII scores increased the risk of gingivitis by 1.64 and 3.94 times, respectively. Males with an elevated DII score had 27.15 times higher odds of being diagnosed with gingivitis and BoP (β = 6.54; p = 0.03). Elderly patients with a moderate or high DII score were less prone to gingivitis and increased BoP (p < 0.04) compared with younger subjects. Considering the DII, there were no differences in microbial alpha and beta diversity; however, distinct species abundance and a higher concentration of monocyte‐chemoattractant protein‐1 and interleukin 33 were seen in patients with a higher DII.Conclusion: A pro‐inflammatory diet significantly contributes to periodontal inflammation, modulating inflammatory biomarkers and affecting the subgingival microbial community in healthy individuals.


  • Comparison between connective tissue graft and xenogeneic acellular dermal matrix to treat single gingival recession: A data reanalysis of randomized clinical trials

    by Manuela Maria Viana Miguel, Laís Fernanda Ferreira Ferraz, Amanda Rossato, Tuana Mendonça Faria Cintra, Ingrid Fernandes Mathias‐Santamaria, Mauro Pedrine Santamaria

    Objectives: There are few studies comparing xenogeneic acellular dermal matrixes (XDMs) with connective tissue graft (CTG) to treat single gingival recession (GR). The present study involved a reanalysis of previous studies and comparison of CTG or XDM to treat single RT1/GR.Materials and methods: Fifty patients from three previous randomized clinical trials treated either by CTG (n = 25) or XDM (n = 25) were evaluated after 6‐month. Clinical, patient‐centered, and esthetic parameters were assessed. Pearson's correlation and regression analyses were also performed.Results: Greater recession reduction (RecRed), percentage of root coverage (%RC), and complete root coverage (CRC) were observed in the CTG group (p ≤ 0.02). Gingival thickness (GT) and keratinized tissue width (KTW) gains were higher in the CTG group. The CTG group showed better esthetic at 6‐month. Logistic analyses reported that GT([OR] = 1.6473) and papilla height (PH) (OR = 8.20) are predictors of CRC. GT*XDM interaction was a negative predictor of CRC (OR = 7.105−5). GT at baseline acted as a predictor of RecRed in both groups (p = 0.03). The XDM graft impacted RecRed and %RC negatively. Baseline PH was a predictor of %RC for both grafts.Conclusion: CTG was superior for treating RT1/GR, providing better root coverage outcomes and tissue gains over time. GT, PH, and graft type were classified as predictors of CRC.Clinical significance: CTG presented better outcomes to treat single RT1 gingival recession when compared to the XDM.